Medexus Pharmaceuticals (TSX:MDP) Change In Inventory: C$7.4 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:MDP Medexus Pharmaceuticals Inc TSX:MDP
54 GF Score
Price C$5.08
GF Value C$1.86
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Medexus Pharmaceuticals Change In Inventory?

Medexus Pharmaceuticals TSX:MDP +0.20% 54 Change In Inventory is C$7.4 Mil as of Mar. 2026. GuruFocus rates TSX:MDP with a GF Score™ of 54/100 and a GF Value™ of C$1.86 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Medexus Pharmaceuticals's change in inventory for the quarter that ended in Mar. 2026 was C$2.9 Mil. It means Medexus Pharmaceuticals's inventory declined by C$2.9 Mil from Dec. 2025 to Mar. 2026 .

Medexus Pharmaceuticals's change in inventory for the fiscal year that ended in Mar. 2026 was C$7.3 Mil. It means Medexus Pharmaceuticals's inventory declined by C$7.3 Mil from Mar. 2025 to Mar. 2026 .

Medexus Pharmaceuticals's Total Inventories for the quarter that ended in Mar. 2026 was C$45.7 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Medexus Pharmaceuticals's Days Inventory for the quarter that ended in Mar. 2026 was 259.66.

Inventory Turnover measures how fast the company turns over its inventory within a year. Medexus Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.35.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Medexus Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.31.

Medexus Pharmaceuticals  (TSX:MDP) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Medexus Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=44.431/15.614*365 / 4
=259.66

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Medexus Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=15.614 / 44.431
=0.35

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Medexus Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=44.431 / 33.823
=1.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medexus Pharmaceuticals Change In Inventory Related Terms

Medexus Pharmaceuticals Change In Inventory Historical Data

* Premium members only.

The historical data trend for Medexus Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medexus Pharmaceuticals Change In Inventory Chart

Medexus Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.43 -2.72 -9.14 -6.61 7.34

Medexus Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.49 -0.65 3.71 1.44 2.89
TSX:MDP
54GF Score
Medexus Pharmaceuticals Inc TSX:MDP
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medexus Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$7.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of C$7.4 Mil mean?
Medexus Pharmaceuticals (TSX:MDP) has a Change In Inventory of C$7.4 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Medexus Pharmaceuticals and its competitors.
Is Medexus Pharmaceuticals' Change In Inventory too high?
Medexus Pharmaceuticals' current Change In Inventory is C$7.4 Mil. Overall, Medexus Pharmaceuticals has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medexus Pharmaceuticals' Change In Inventory compare to ZTS and UTHR?
Medexus Pharmaceuticals' Change In Inventory of C$7.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Medexus Pharmaceuticals and its competitors. Medexus Pharmaceuticals's current Change In Inventory is C$7.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medexus Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Medexus Pharmaceuticals (TSX:MDP) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.86, compared to a current price of C$5.08 — trading 173.1% above its estimated fair value. The current Change In Inventory is C$7.4 Mil. Medexus Pharmaceuticals' overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Medexus Pharmaceuticals (TSX:MDP), the current Change In Inventory is C$7.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medexus Pharmaceuticals (TSX:MDP) Overvalued in 2026?

Based on GuruFocus' analysis, Medexus Pharmaceuticals stock appears to be overvalued. The current stock price of C$5.08 is trading 173.1% above its estimated GF Value™ of C$1.86. GuruFocus considers Medexus Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for TSX:MDP:

  • Change In Inventory: C$7.4 Mil
  • GF Value™: C$1.86 vs. price of C$5.08 (173.1% above fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the TSX:MDP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medexus Pharmaceuticals Business Description

Other Exchanges MEDXF:USAP731:Germany
Address 10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Medexus products are generally sold in North America to wholesalers, distributors, government agencies, healthcare facilities and specialty pharmacies.
54GF Score

Get the complete analysis for TSX:MDP

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$5.08
Price
C$1.86
GF Value